300363 博腾股份
已收盘 08-26 15:00:00
资讯
新帖
简况
博腾股份：8月24日接受机构调研，东方证券、华福证券等多家机构参与
证券之星 · 08-25 09:36
博腾股份：8月24日接受机构调研，东方证券、华福证券等多家机构参与
博腾股份(300363)7月10日股东户数4.8万户，较上期减少0.2%
证券之星 · 08-22
博腾股份(300363)7月10日股东户数4.8万户，较上期减少0.2%
图解博腾股份中报：第二季度单季净利润同比下降904.20%
证券之星 · 08-22
图解博腾股份中报：第二季度单季净利润同比下降904.20%
博腾股份（300363）披露2026年半年度报告，8月21日股价下跌10.58%
证券之星 · 08-21
博腾股份（300363）披露2026年半年度报告，8月21日股价下跌10.58%
博腾股份(300363.SZ)发布上半年业绩，由盈转亏2.24亿元
智通财经 · 08-21
博腾股份(300363.SZ)发布上半年业绩，由盈转亏2.24亿元
8月7日博腾股份（300363）龙虎榜数据：机构净买入4759.01万元，北向资金净买入4894.9万元
证券之星 · 08-07
8月7日博腾股份（300363）龙虎榜数据：机构净买入4759.01万元，北向资金净买入4894.9万元
博腾股份最新公告：控股子公司取得药品生产许可证已具备承接细胞与基因治疗产品商业化受托生产的合规资质
证券之星 · 08-03
博腾股份最新公告：控股子公司取得药品生产许可证已具备承接细胞与基因治疗产品商业化受托生产的合规资质
博腾股份：Payload-linker相关服务是公司新分子业务的服务内容之一
证券之星 · 07-28
博腾股份：Payload-linker相关服务是公司新分子业务的服务内容之一
公司问答丨博腾股份：公司设立全资子公司曜初生物主要是探索大健康消费品领域 目前处于成立初期
格隆汇 · 07-27
公司问答丨博腾股份：公司设立全资子公司曜初生物主要是探索大健康消费品领域 目前处于成立初期
博腾股份（300363）披露公司股东取保候审公告，7月22日股价下跌0.6%
证券之星 · 07-22
博腾股份（300363）披露公司股东取保候审公告，7月22日股价下跌0.6%
博腾股份：股东陶荣因非国家工作人员受贿案被取保候审
格隆汇 · 07-22
博腾股份：股东陶荣因非国家工作人员受贿案被取保候审
殷瑞飞2026年二季度表现，国投瑞银上证科创板综合价格指数增强A基金季度涨幅43.68%
证券之星 · 07-21
殷瑞飞2026年二季度表现，国投瑞银上证科创板综合价格指数增强A基金季度涨幅43.68%
博腾股份（300363）披露回购公司股份实施完毕公告，7月20日股价上涨3.04%
证券之星 · 07-20
博腾股份（300363）披露回购公司股份实施完毕公告，7月20日股价上涨3.04%
7月17日博腾股份跌14.13%，招商中证1000指数增强A基金重仓该股
证券之星 · 07-17
7月17日博腾股份跌14.13%，招商中证1000指数增强A基金重仓该股
博腾股份：截至2026年7月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为48,036户
证券之星 · 07-17
博腾股份：截至2026年7月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为48,036户
博腾股份（300363）披露拟新设全资子公司公告，7月16日股价下跌0.53%
证券之星 · 07-16
博腾股份（300363）披露拟新设全资子公司公告，7月16日股价下跌0.53%
博腾股份(300363.SZ)拟3000万元设立全资子公司探索健康消费品业务
智通财经 · 07-15
博腾股份(300363.SZ)拟3000万元设立全资子公司探索健康消费品业务
博腾股份（300363）披露2026年半年度业绩预告，7月15日股价上涨2.89%
证券之星 · 07-15
博腾股份（300363）披露2026年半年度业绩预告，7月15日股价上涨2.89%
博腾股份：预计2026年1-6月扣非后净利润亏损2.3亿元至2.7亿元
证券之星 · 07-14
博腾股份：预计2026年1-6月扣非后净利润亏损2.3亿元至2.7亿元
7月6日博腾股份涨6.33%，招商中证1000指数增强A基金重仓该股
证券之星 · 07-06
7月6日博腾股份涨6.33%，招商中证1000指数增强A基金重仓该股
加载更多
公司概况
公司名称：
重庆博腾制药科技股份有限公司
所属行业：
医药制造业
上市日期：
2014-01-29
主营业务：
重庆博腾制药科技股份有限公司的主营业务是为小分子药物、大分子药物及基因细胞治疗等不同类型的药物及疗法提供CDMO服务。公司的主要产品是小分子原料药业务、小分子制剂业务、细胞与基因治疗业务、新分子业务。报告期内，公司连续第三年获得某跨国制药公司颁发的“EHS外部合作伙伴卓越奖”荣誉。
发行价格：
25.10
{"stockData":{"symbol":"300363","market":"SZ","secType":"STK","nameCN":"博腾股份","latestPrice":20.58,"timestamp":1787727801000,"preClose":20.88,"halted":0,"volume":32582134,"delay":0,"changeRate":-0.0144,"floatShares":499000000,"shares":543000000,"eps":-0.2851,"marketStatus":"已收盘","change":-0.3,"latestTime":"08-26 15:00:00","open":21.18,"high":21.37,"low":20.1,"amount":674000000,"amplitude":0.0608,"askPrice":20.59,"askSize":44,"bidPrice":20.58,"bidSize":122,"shortable":0,"etf":0,"ttmEps":-0.2851,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787794200000},"marketStatusCode":5,"adr":0,"adjPreClose":20.88,"symbolType":"stock","openAndCloseTimeList":[[1787707800000,1787715000000],[1787720400000,1787727600000]],"highLimit":22.97,"lowLimit":18.79,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":543442176,"isCdr":false,"pbRate":2.29,"roa":"--","roe":"--","epsLYR":0.18,"committee":-0.095819,"marketValue":11184000000,"turnoverRate":0.0653,"status":1,"floatMarketCap":10266000000},"requestUrl":"/m/hq/s/300363","defaultTab":"news","newsList":[{"id":"2662781207","title":"博腾股份：8月24日接受机构调研，东方证券、华福证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2662781207","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662781207?lang=zh_cn&edition=full","pubTime":"2026-08-25 09:36","pubTimestamp":1787621795,"startTime":"0","endTime":"0","summary":"今年上半年，CGT 新签订单约 9,188 万元，同比增长约 75%，其中来自海外客户的订单占比达 38%。1上半年，PI 产品收入下滑主要因两个商业化项目交付节奏原因，后续发货等相关安排将根据客户要求确认。博腾股份主营业务：小分子原料药业务,小分子制剂业务,基因细胞治疗业务,新分子业务。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500014707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","161027","BK0028","300363","BK1147","BK0276","BK0183","BK1564","600958","03958","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661921624","title":"博腾股份(300363)7月10日股东户数4.8万户，较上期减少0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661921624","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661921624?lang=zh_cn&edition=full","pubTime":"2026-08-22 17:09","pubTimestamp":1787389768,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博腾股份披露，截至2026年7月10日公司股东户数为4.8万户，较6月30日减少98.0户，减幅为0.2%。在医疗服务行业个股中，博腾股份股东户数高于行业平均水平，截至7月10日，医疗服务行业平均股东户数为4.78万户。从股价来看，2026年6月30日至2026年7月10日，博腾股份区间涨幅为13.42%，在此期间股东户数减少98.0户，减幅为0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200015067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294023","title":"图解博腾股份中报：第二季度单季净利润同比下降904.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294023","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661294023?lang=zh_cn&edition=full","pubTime":"2026-08-22 01:56","pubTimestamp":1787335005,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份2026年中报显示，上半年度公司主营收入17.9亿元，同比上升10.42%；归母净利润-2.24亿元，同比下降928.55%；扣非净利润-2.47亿元，同比下降3943.67%；其中2026年第二季度，公司单季度主营收入9.04亿元，同比上升10.25%；单季度归母净利润-2.52亿元，同比下降904.2%；单季度扣非净利润-2.72亿元，同比下降1744.54%；负债率35.4%，投资收益565.89万元，财务费用1775.29万元，毛利率32.23%。财报数据概要请见下图:本文数据来源于博腾股份2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200002074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296857","title":"博腾股份（300363）披露2026年半年度报告，8月21日股价下跌10.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296857","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661296857?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:04","pubTimestamp":1787321073,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，博腾股份报收于21.89元，较前一交易日下跌10.58%，最新总市值为118.96亿元。该股当日开盘23.33元，最高23.33元，最低21.38元，成交额达14.98亿元，换手率为13.75%。近日，博腾股份披露《2026年半年度报告》。经营活动产生的现金流量净额305,704,423.69元，同比增长22.19%。总资产7,854,647,700.93元，较上年度末减少8.14%；归属于上市公司股东的净资产4,956,981,575.93元，较上年度末减少7.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100044990.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293638","title":"博腾股份(300363.SZ)发布上半年业绩，由盈转亏2.24亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293638","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661293638?lang=zh_cn&edition=full","pubTime":"2026-08-21 21:07","pubTimestamp":1787317649,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博腾股份(300363.SZ)发布2026年半年度报告，报告期内，公司实现营业收入17.9亿元，同比增长10.42%。归属于上市公司股东净亏损2.24亿元。归属于上市公司股东的扣除非经常性损益净亏损2.47亿元。主要由于公司终止斯洛文尼亚投资项目相关资产减值准备3.30亿元。2026年上半年，公司持续经营净利润9,232.77万元，同比增长约329%，盈利改善的主要原因公司营业收入规模化效应显现，带动公司整体毛利率提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","300363","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614833","title":"8月7日博腾股份（300363）龙虎榜数据：机构净买入4759.01万元，北向资金净买入4894.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657614833?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:44","pubTimestamp":1786095870,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月7日公布的交易公开信息显示，博腾股份因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年8月7日收盘，博腾股份报收于20.44元，上涨20.02%，涨停，换手率14.77%，成交量73.17万手，成交额13.83亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入4759.01万元，北向资金合计净买入4894.9万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700030581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300363","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656378284","title":"博腾股份最新公告：控股子公司取得药品生产许可证已具备承接细胞与基因治疗产品商业化受托生产的合规资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2656378284","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656378284?lang=zh_cn&edition=full","pubTime":"2026-08-03 18:41","pubTimestamp":1785753664,"startTime":"0","endTime":"0","summary":"博腾股份(300363.SZ)公告称，公司二级控股子公司苏州博腾生物制药有限公司近日取得江苏省药品监督管理局核发的《药品生产许可证》，有效期至2031年7月26日。该许可证标志着苏州博腾已具备承接细胞与基因治疗产品商业化受托生产的合规资质，有利于促进公司细胞与基因治疗CDMO业务开展。本次取得《药品生产许可证》预计不会对公司2026年度业绩产生重大影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300029188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654792710","title":"博腾股份：Payload-linker相关服务是公司新分子业务的服务内容之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2654792710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654792710?lang=zh_cn&edition=full","pubTime":"2026-07-28 15:06","pubTimestamp":1785222381,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份(300363)07月27日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好，目前创新药Payload需求旺盛，请问对于公司有何影响？博腾股份回复：您好，Payload-linker相关服务是公司新分子业务的服务内容之一，公司已在中国上海及美国新泽西建立了高活设施和能力，可承接临床前到商业化阶段的研发生产服务。新分子业务属于公司新兴业务之一，整体收入占公司营业收入比例较小。2025年实现收入0.68亿元，同比增长224%，占公司整体营业收入约2%。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800019313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654090577","title":"公司问答丨博腾股份：公司设立全资子公司曜初生物主要是探索大健康消费品领域 目前处于成立初期","url":"https://stock-news.laohu8.com/highlight/detail?id=2654090577","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654090577?lang=zh_cn&edition=full","pubTime":"2026-07-27 15:35","pubTimestamp":1785137758,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK0028","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653657017","title":"博腾股份（300363）披露公司股东取保候审公告，7月22日股价下跌0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653657017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653657017?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:18","pubTimestamp":1784729899,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，博腾股份报收于16.66元，较前一交易日下跌0.6%，最新总市值为90.54亿元。博腾股份于近日披露《关于公司股东取保候审的公告》。公告显示，公司股东陶荣先生因涉及非国家工作人员受贿案，于2026年7月18日应中山市公安局通知接受调查，并于2026年7月20日起被采取取保候审措施。公司表示将密切关注事件进展，并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300363","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653751284","title":"博腾股份：股东陶荣因非国家工作人员受贿案被取保候审","url":"https://stock-news.laohu8.com/highlight/detail?id=2653751284","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653751284?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:42","pubTimestamp":1784716974,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK0028","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653209443","title":"殷瑞飞2026年二季度表现，国投瑞银上证科创板综合价格指数增强A基金季度涨幅43.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653209443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653209443?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:43","pubTimestamp":1784648625,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2026年二季度末，基金经理殷瑞飞旗下共管理18只基金，本季度表现最佳的为国投瑞银上证科创板综合价格指数增强A，季度净值涨43.68%。持有期间的估算收益率为146.79%，持有期间洛阳钼业在2024年到2025年的年报归属净利润增幅达50.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2580892862.HKD","LU0572944931.SGD","LU1997245177.USD","LU2039709279.SGD","LU0228659784.USD","LU2495084118.USD","LU1303224171.USD","BK0242","LU1997244956.HKD","LU1820825898.SGD","BK0028","SGXZ81163826.USD","LU0456842615.SGD","LU2476274308.USD","BK0188","LU0828237510.HKD","BK0183","603993","SGXZ49509284.SGD","06809","LU0269904917.USD","LU1997245094.SGD","BK0214","LU0327786744.USD","LU0509642566.USD","BK0012","LU1719994722.HKD","BK0196","LU2778985437.USD","688008","300363","LU1770034418.SGD","BK0239","LU2580892789.USD","BK0056","LU2476274720.SGD","LU1251922891.USD","03993","LU1146622755.USD","LU0828238088.HKD","BK0182","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652211865","title":"博腾股份（300363）披露回购公司股份实施完毕公告，7月20日股价上涨3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652211865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652211865?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:09","pubTimestamp":1784556555,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘，博腾股份报收于16.6元，较前一交易日上涨3.04%，最新总市值为90.21亿元。该股当日开盘16.3元，最高17.06元，最低16.08元，成交额达4.77亿元，换手率为5.81%。近日，博腾股份发布《关于回购公司股份实施完毕的公告》。公告显示，公司于2026年6月5日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，拟用于注销并减少注册资本。本次回购已实施完毕，符合既定方案及相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000039346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652406448","title":"7月17日博腾股份跌14.13%，招商中证1000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652406448","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652406448?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:51","pubTimestamp":1784278305,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日博腾股份跌14.13%，收盘报16.11元，换手率8.6%，成交量42.63万手，成交额7.26亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共12家，其中持有数量最多的公募基金为招商基金的招商中证1000指数增强A。招商中证1000指数增强A目前规模为10.48亿元，最新净值2.0743，较上一交易日下跌2.38%，近一年上涨16.78%。招商中证1000指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652291473","title":"博腾股份：截至2026年7月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为48,036户","url":"https://stock-news.laohu8.com/highlight/detail?id=2652291473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652291473?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:51","pubTimestamp":1784249468,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份(300363)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止7月10日公司股东户数是多少？谢谢博腾股份回复：截至2026年7月10日收盘，公司股东总户数（合并普通账户和融资融券信用账户）为48,036户。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700007648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410290","title":"博腾股份（300363）披露拟新设全资子公司公告，7月16日股价下跌0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651410290?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:21","pubTimestamp":1784193666,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，博腾股份报收于18.76元，较前一交易日下跌0.53%，最新总市值为101.95亿元。该股当日开盘18.69元，最高19.2元，最低17.85元，成交额达7.63亿元，换手率为8.32%。近日，博腾股份披露《关于拟新设全资子公司的公告》。公告显示，公司拟以自有资金3,000万元人民币新设全资子公司重庆市曜初生物科技有限公司，探索健康消费品市场机会。公司已于2026年7月15日召开第六届董事会第十一次临时会议，审议通过该投资事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600028045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651664074","title":"博腾股份(300363.SZ)拟3000万元设立全资子公司探索健康消费品业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2651664074","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651664074?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:36","pubTimestamp":1784122568,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博腾股份(300363.SZ)发布公告，公司拟以自有资金3000万元新设全资子公司重庆市曜初生物科技有限公司(暂定名)。公司此次新设全资子公司，主要为探索健康消费品业务，对公司未来发展具有积极意义。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"博腾股份(300363.SZ)拟3000万元设立全资子公司探索健康消费品业务","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300363","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651456477","title":"博腾股份（300363）披露2026年半年度业绩预告，7月15日股价上涨2.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651456477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651456477?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:23","pubTimestamp":1784107402,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，博腾股份报收于18.86元，较前一交易日上涨2.89%，最新总市值为102.49亿元。该股当日开盘18.0元，最高19.75元，最低17.88元，成交额达10.6亿元，换手率为11.33%。近日，重庆博腾制药科技股份有限公司发布2026年半年度业绩预告，预计报告期内实现营业收入17.5亿元至18.2亿元，同比增长8%至12%。剔除该影响后，公司预计实现归属于上市公司股东的净利润8000万元至1.2亿元，同比增长196%至343%，核心业务盈利能力提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500032886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300363","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651617477","title":"博腾股份：预计2026年1-6月扣非后净利润亏损2.3亿元至2.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651617477","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651617477?lang=zh_cn&edition=full","pubTime":"2026-07-14 18:12","pubTimestamp":1784023955,"startTime":"0","endTime":"0","summary":"证券之星消息，博腾股份发布业绩预告，预计2026年1-6月扣非后净利润亏损2.3亿元至2.7亿元。报告期内，公司非经常性损益对净利润的影响金额约为 2,221 万元，去年同期为 2,064 万元。博腾股份2026年一季报显示，一季度公司主营收入8.86亿元，同比上升10.59%；归母净利润2786.51万元，同比上升750.41%；扣非净利润2471.12万元，同比上升344.9%；负债率35.31%，投资收益-25.87万元，财务费用1638.11万元，毛利率30.6%。本文数据来源于《博腾股份:2026年半年度业绩预告》，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400038210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300363"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649764274","title":"7月6日博腾股份涨6.33%，招商中证1000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649764274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649764274?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:42","pubTimestamp":1783327377,"startTime":"0","endTime":"0","summary":"证券之星消息，7月6日博腾股份涨6.33%，收盘报17.97元，换手率10.24%，成交量50.76万手，成交额9.19亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共12家，其中持有数量最多的公募基金为招商基金的招商中证1000指数增强A。招商中证1000指数增强A目前规模为10.48亿元，最新净值2.3886，较上一交易日上涨0.76%，近一年上涨38.25%。招商中证1000指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600022373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300363","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787770990562,"stockEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.2541},{"period":"3month","weight":0.3887},{"period":"6month","weight":-0.1213},{"period":"1year","weight":-0.1432},{"period":"ytd","weight":-0.1107}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0141},{"period":"3month","weight":-0.0454},{"period":"6month","weight":-0.0601},{"period":"1year","weight":0.0114},{"period":"ytd","weight":-0.0142}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆博腾制药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"48036人(较上一季度减少0.20%)","perCapita":"10385股","listingDate":"2014-01-29","address":"重庆市长寿区(长寿)化工园区精细化工一区","registeredCapital":"54344万元","survey":" 重庆博腾制药科技股份有限公司的主营业务是为小分子药物、大分子药物及基因细胞治疗等不同类型的药物及疗法提供CDMO服务。公司的主要产品是小分子原料药业务、小分子制剂业务、细胞与基因治疗业务、新分子业务。报告期内，公司连续第三年获得某跨国制药公司颁发的“EHS外部合作伙伴卓越奖”荣誉。","listedPrice":25.1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博腾股份(300363)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博腾股份(300363)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博腾股份,300363,博腾股份股票,博腾股份股票老虎,博腾股份股票老虎国际,博腾股份行情,博腾股份股票行情,博腾股份股价,博腾股份股市,博腾股份股票价格,博腾股份股票交易,博腾股份股票购买,博腾股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博腾股份(300363)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博腾股份(300363)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}